|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
5R21CA218976-02
|
$238,815
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers
|
1U01CA226055-01
|
$768,101
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-10
|
$461,172
|
$230,586
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Detection of somatic, subclonal and mosaic CNVs from sequencing
|
1U24CA220242-01A1
|
$559,916
|
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Elucidation and therapeutic exploitation of PAK mediated radioresistance
|
1R37CA215081-01A1
|
$357,803
|
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
5R01CA140368-07
|
$369,313
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Assessment of sensory gating, attention, and executive control in breast cancer
|
1R01CA218496-01A1
|
$687,576
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-03
|
$459,505
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The cohesin complex as a tumor suppressor in myeloid leukemia
|
5R01CA216421-02
|
$511,640
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Advancing the translatability of mouse models for cancer immunotherapy
|
1R01CA210561-01A1
|
$587,737
|
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Lymphatic and systemic immunity changes in post-radiation lymphedema development
|
5R01CA201487-03
|
$357,343
|
|
ALDRICH, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Targeting transducin Beta-like protein 1 in mantle cell lymphoma
|
1K08CA226352-01
|
$227,046
|
|
ALINARI, LAPO
|
OHIO STATE UNIVERSITY
|
|
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
|
5U01CA194389-04
|
$632,932
|
|
ALIZADEH, ARASH
|
STANFORD UNIVERSITY
|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
5UG3CA211415-02
|
$338,933
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Quantitative MRI Radiomics of Breast Cancer in Assessment of Malignancy and Response to Therapy
|
1F31CA221193-01A1
|
$26,048
|
|
ANTROPOVA, NATALIA
|
UNIVERSITY OF CHICAGO
|
|
Targeted therapies in mutant BRAF melanoma
|
5R01CA182635-05
|
$321,625
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Mutant BRAF-regulated transcription factors in melanoma progression
|
5R01CA196278-04
|
$356,850
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Elucidating transcription regulation by epigenetics in neuroblastoma
|
1K08CA226237-01
|
$206,394
|
|
APPLEBAUM, MARK
|
UNIVERSITY OF CHICAGO
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
HER2-pretargeting image-guided therapy of breast cancer
|
5R01CA209884-02
|
$393,896
|
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$159,088
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$1,680
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$4,130
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$5,157
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Cancer Etiology, Prevention, Detection and Diagnosis
|
2T32CA009302-41
|
$449,025
|
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
$176,138
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design
|
1R01CA225615-01
|
$632,908
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
$117,383
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Taxol for this search: $30,910,390
|